BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23973310)

  • 1. Minoxidil sulfate induced the increase in blood-brain tumor barrier permeability through ROS/RhoA/PI3K/PKB signaling pathway.
    Gu YT; Xue YX; Wang YF; Wang JH; Chen X; ShangGuan QR; Lian Y; Zhong L; Meng YN
    Neuropharmacology; 2013 Dec; 75():407-15. PubMed ID: 23973310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
    Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
    J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine 5'-triphosphate-sensitive potassium channel activator induces the up-regulation of caveolin-1 expression in a rat brain tumor model.
    Gu YT; Xue YX; Zhang H; Li Y; Liang XY
    Cell Mol Neurobiol; 2011 May; 31(4):629-34. PubMed ID: 21331626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood-brain tumor barrier permeability increase in a rat brain tumor model.
    Ningaraj NS; Rao MK; Black KL
    Cancer Res; 2003 Dec; 63(24):8899-911. PubMed ID: 14695207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NS1619 regulates the expression of caveolin-1 protein in a time-dependent manner via ROS/PI3K/PKB/FoxO1 signaling pathway in brain tumor microvascular endothelial cells.
    Cai RP; Xue YX; Huang J; Wang JH; Wang JH; Zhao SY; Guan TT; Zhang Z; Gu YT
    J Neurol Sci; 2016 Oct; 369():109-118. PubMed ID: 27653874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
    Zhang Z; Xia C; Xue Y; Liu Y
    J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
    Xie H; Xue YX; Liu LB; Liu YH; Wang P
    J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium-activated potassium channel activator down-regulated the expression of tight junction protein in brain tumor model in rats.
    Gu YT; Xue YX; Wei XY; Zhang H; Li Y
    Neurosci Lett; 2011 Apr; 493(3):140-4. PubMed ID: 21334421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulation of protein kinase A and heat shock protein 70 is involved in the reversible increase of blood-brain tumor barrier permeability induced by papaverine.
    Wang ZH; Xue YX; Liu YH
    Brain Res Bull; 2010 Nov; 83(6):367-73. PubMed ID: 20728510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-132-3p boosts caveolae-mediated transcellular transport in glioma endothelial cells by targeting PTEN/PI3K/PKB/Src/Cav-1 signaling pathway.
    Gu Y; Cai R; Zhang C; Xue Y; Pan Y; Wang J; Zhang Z
    FASEB J; 2019 Jan; 33(1):441-454. PubMed ID: 30024792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA-mediated potential regulation of blood-tumor barrier permeability by bradykinin.
    Ma T; Xue Y
    J Mol Neurosci; 2010 Sep; 42(1):67-73. PubMed ID: 20369389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
    Duan M; Xing Y; Guo J; Chen H; Zhang R
    Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin.
    Liu LB; Liu XB; Ma J; Liu YH; Li ZQ; Ma T; Zhao XH; Xi Z; Xue YX
    Biochem Biophys Res Commun; 2015 Aug; 464(1):118-25. PubMed ID: 26106824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ΞΆ/PP2A-dependent signaling mechanism.
    Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
    Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
    Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of KCa and KATP agonists on brain tumor permeability between syngeneic and allogeneic rat models.
    Black KL; Yin D; Konda BM; Wang X; Hu J; Ko MK; Bayan JA; Sacapano MR; Espinoza AJ; Ong JM; Irvin D; Shu Y
    Brain Res; 2008 Aug; 1227():198-206. PubMed ID: 18602898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
    Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB
    J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.